Related Experiment Videos
Onchocerciasis treated with diethylcarbamazine
The British Journal of Dermatology
|November 1, 1977
Summary
Diethylcarbamazine effectively treated onchocerciasis in 48% of patients after one course. However, predicting which individuals would achieve cure with a single treatment course remains challenging.
Area of Science:
- Medical Parasitology
- Tropical Diseases
- Public Health
Background:
- Onchocerciasis, a filarial nematode infection, causes significant morbidity globally.
- Diethylcarbamazine (DEC) is a standard treatment for onchocerciasis.
Purpose of the Study:
- To evaluate the efficacy of a single course of diethylcarbamazine in treating onchocerciasis.
- To identify predictors for successful single-course treatment outcomes.
Main Methods:
- A cohort of 100 onchocerciasis patients received a single course of diethylcarbamazine.
- Clinical cure was assessed post-treatment.
Main Results:
- A single course of diethylcarbamazine resulted in clinical cure for 48% of the patients.
- No predictive factors were identified to determine which patients would benefit from a single treatment course.
Conclusions:
- Diethylcarbamazine demonstrates moderate efficacy with a single treatment course for onchocerciasis.
- Further research is needed to develop strategies for optimizing treatment outcomes and patient selection.